Tag: Nms

An estimated 0.02 to 3 percent of patients taking antipsychotic agents may develop neuroleptic malignant syndrome (NMS). When this occurs, physicians often **give lorazepam for neuroleptic malignant syndrome** as a first-line intervention to help manage severe symptoms, including muscle rigidity and agitation.

While clinical trials often report a relatively low incidence of certain cardiovascular issues with Abilify (aripiprazole) compared to some other antipsychotics, official sources and case reports confirm that rare but serious events like chest pain can occur. Therefore, it is critical to understand the potential link between **Can Abilify cause chest pain?** and to know when to seek immediate medical help.

According to clinical trial data, extrapyramidal symptoms (EPS), a group of movement-related problems, were reported in up to 36.7% of patients receiving risperidone. Understanding the connection between risperidone and muscular effects is crucial for anyone taking this medication, as it can range from mild discomfort to more serious, long-term conditions.

According to research, between 30% and 50% of prescribed medicines are not taken as intended by patients, highlighting a significant challenge in medication management. An **NMS pharmacy** participates in the New Medicine Service, a program designed to address this issue by providing extra support for those starting new long-term condition medicines.